# NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

> **NCT07224152** · PHASE1,PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Locally-Advanced Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** NBTXR3

## Key facts

- **NCT ID:** NCT07224152
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-27
- **Primary completion:** 2028-08-30
- **Final completion:** 2030-08-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224152, "NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07224152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*